Skip to main content
Clinical Trials/NCT06083818
NCT06083818Not yet recruitingNot Applicable

Therapeutic Exercise Protocol for the Prevention of Anterior Cruciate Ligament Injuries in Female Football Players With Dynamic Knee Valgus

Amanda Coves García2 sites in 1 country48 target enrollmentStarted: October 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
48
Locations
2
Primary Endpoint
MOTOR CONTROL

Study Overview

Brief Summary

Introduction: Women's football has experienced exponential growth over the last ten years. Its popularity is associated with an increase in anterior cruciate ligament injuries (ACL). They constitute a major current problem as they account for 43% of the injury burden during the sport season. Despite existing training programmes, no uniform criteria have been established to design a precise intervention protocol, with specific tasks linked to women's football, nor has it been proposed to optimise current programmes.

Objective: To evaluate the efficacy of a comprehensive and specific training protocol focused on female football players with dynamic knee valgus (DKV) to prevent ACL injuries.

Methodology: Randomised, double-blind, single-centre clinical trial protocol scheduled for the 2023-2024 season of women's football. There will be 2 groups: a group that will follow a specific ACL injury prevention protocol and a control group. The intervention period will last 12 weeks. Measurements will be taken at 3 time points. The biomechanics of the lower extremities, the dynamics of jumping and landing, as well as the pre and post training satisfaction of the players will be evaluated. Image capture and processing systems will be used in addition to tests such as the drop vertical jump test (DVJ), the LESS scoring system, among others.

Future expectations: This protocol aims to be one of the first to implement an ACL injury prevention programme for women football players with DKV. Despite the scarcity of research in this area, studies support beneficial effects at a preventive level.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Outcomes Assessor)

Masking Description

Double blind masking

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Female football players registered and federated in the corresponding team.
  • With an age range between 18 and 35 years old.
  • Minimum experience of one year playing football.
  • With DKV presence.

Exclusion Criteria

  • Subjects with previous ACL or other ligamentous injury to the knee.
  • Subjects with a history of lower extremity injury resulting in surgery during the six months prior to the study.
  • Players with chronic illnesses that may affect test results.
  • Subjects who played other sports at a professional level.

Outcomes

Primary Outcomes

MOTOR CONTROL

Time Frame: 12 weeks

Changes in motor control not only of the lower limbs, but also of the lumbo-pelvic complex using software and imaging systems that measure joint alignments.

KNEE JOINT BIOMECHANICS

Time Frame: 12 weeks

Changes in neuromuscular control of the knee using imaging and force plate assessments to monitor lower limb alignment and areas of increased reaction force.

CHANGING RISK FACTORS

Time Frame: 12 weeks

modification of risk factors such as dynamic knee valgus

SPORT PERFORMANCE

Time Frame: 12 weeks

Tactical and technical changes are expected on the pitch as well as improvements in the sporting performance of the players through dynamic evaluations with imaging and video systems as well as speed and agility tests by monitoring joint stability.

SPORTSWOMEN SATISFACTION

Time Frame: 12 weeks

Changes in the incidence of injuries among female football players using the SF-12 satisfaction scale.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Amanda Coves García
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Amanda Coves García

Principal Investigator

Universidad Miguel Hernandez de Elche

Study Sites (2)

Loading locations...

Similar Trials